These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8259417)

  • 1. MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations.
    Vanel D; Shapeero LG; De Baere T; Gilles R; Tardivon A; Genin J; Guinebretière JM
    Radiology; 1994 Jan; 190(1):263-8. PubMed ID: 8259417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media].
    Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C
    Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
    Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
    Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
    Teo EL; Strouse PJ; Hernandez RJ
    AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging.
    Biondetti PR; Ehman RL
    Radiology; 1992 Jun; 183(3):845-8. PubMed ID: 1584945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of soft-tissue tumors: fast STIR sequence as substitute for T1-weighted fat-suppressed contrast-enhanced spin-echo sequence.
    Tokuda O; Harada Y; Matsunaga N
    AJR Am J Roentgenol; 2009 Dec; 193(6):1607-14. PubMed ID: 19933655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy.
    Vanel D; Lacombe MJ; Couanet D; Kalifa C; Spielmann M; Genin J
    Radiology; 1987 Jul; 164(1):243-5. PubMed ID: 3588913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of malignant soft-tissue tumors.
    Hanna SL; Fletcher BD
    Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):629-50. PubMed ID: 8564687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis.
    Wetzel LH; Levine E
    AJR Am J Roentgenol; 1990 Nov; 155(5):1025-30. PubMed ID: 2120930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnetic resonance in the diagnosis and follow-up of soft-tissue sarcomas].
    Marano I; Brunetti A; Covello M; Belfiore G; Giovine S; Salvatore M
    Radiol Med; 1992; 84(1-2):15-21. PubMed ID: 1509133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.
    Kinkel K; Ariche M; Tardivon AA; Spatz A; Castaigne D; Lhomme C; Vanel D
    Radiology; 1997 Jul; 204(1):55-63. PubMed ID: 9205223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep fascial hyperintensity in soft-tissue abnormalities as revealed by T2-weighted MR imaging.
    Loh NN; Ch'en IY; Cheung LP; Li KC
    AJR Am J Roentgenol; 1997 May; 168(5):1301-4. PubMed ID: 9129430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA; Caputo GR; Steinbach LS
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance in neoplasms of the adipose, fibrous and muscular tissues].
    Balzarini L; Ceglia E; Petrillo R; Tesoro Tess JD; Reitano A; Musumeci R
    Radiol Med; 1989; 77(1-2):87-93. PubMed ID: 2538866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
    Merkle EM; Nour SG; Lewin JS
    Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.